EPO and hip fracture: In the near future, the Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period (PAHFRAC-01) project, a prospective randomised multicentre study (NCT01154491), will provide further insight into the benefit of i.v. iron and epoetin alpha treatment in patients with hip fracture [294].